Labshake search

1051 - 1059 of 1059 citations for Recombinant Human MUC1 Fc tagged since 2019

• Genomic characteristics and clinical significance of CD56+ Circulating Tumor Cells in Small Cell Lung Cancer

  C. Ricordel, et al., bioRxiv - Cancer Biology 2023

  Quote: The first step consists in a CTC enrichment from whole blood sample by immunomagnetic negative selection using the EasySep™ Direct Human CTC Enrichment Kit (StemCell Technologies®, Vancouver, Canada) according to manufacturer instruction ...
• Autofluorescence lifetime flow cytometry with time‐correlated single photon counting

  Kayvan Samimi, et al., bioRxiv - Cell Biology 2024

  Quote: Primary human T cells were isolated from the peripheral blood of a healthy donor using a negative selection kit (EasySep, STEMCELL Technologies Canada Inc., Vancouver, BC) and used for testing the sensitivity of the lifetime flow system to T cell activation ...
• Measuring single-cell density with high throughput enables dynamic profiling of immune cell and drug response from patient samples

  Weida Wu, et al., bioRxiv - Bioengineering 2024

  Quote: ... PBMC samples were thawed on the day of activation and T cells were purified via the EasySep™ Human CD8+ T Cell Enrichment Kit (StemCell Technologies Inc, cat#19053). Isolated T cells were seeded in the CD3/CD28 precoated well plates at a concentration of 500,000 cells/mL with 1 mL/well in ImmunoCult™-XF T Cell Expansion Medium (StemCell Technologies Inc ...
• Association of CD44⁻/CD24⁻ Breast Cancer Cells with Late Stage Tumor Recurrence

  Xinbo Qiao, et al., bioRxiv - Physiology 2020

  Quote: ... were then cultured in the complete L15 medium or the stem cell (SC) medium (10% human MammoCult Proliferation Supplements in MammoCult Basal Medium, Stem Cell Technologies, San Diego, CA, USA) for 7 days ...
• Cyclophilin A protects HIV-1 from restriction by human TRIM5α

  Kyusik Kim, et al., bioRxiv - Microbiology 2019

  Quote: ... CD4+ T cells at 106 cells/mL were stimulated with 25 μL/mL ImmunoCult™ Human CD3/CD28 T Cell Activator (STEMCELL Technologies, Vancouver, Canada, catalogue #10991). At day 3 post-stimulation ...
• Phenotypic, molecular and functional characterisation of human in vitro-generated IL-17A+ CD8+ T-cells

  Elizabeth H. Gray, et al., bioRxiv - Immunology 2022

  Quote: ... CD8+ T-cells were negatively isolated from PBMC by magnetic separation using the EasySep Human CD8+ T-Cell Enrichment Kit (Stemcell Technologies; average purity 93%, n=16).
• Reprogramming of breast tumor-associated macrophages with modulation of arginine metabolism

  Veani Fernando, et al., bioRxiv - Cancer Biology 2023

  Quote: ... T cells were then isolated using EasySep™ Human T Cell Isolation Kit and EasySep™ Magnet (Stemcell Technologies, Cat. No. 17951 and Cat. No. 18000) following manufacturer’s protocol ...
• Myelodysplastic syndromes disable support of human hematopoietic stem and progenitor cells by CD271, VCAM- 1 and CD146 expressing marrow niche cells

  Yuko Kawano, et al., bioRxiv - Cancer Biology 2023

  Quote: ... supplemented with 3 units/ml of human EPO (Peprotec, #100-64) and 10 ng/ml of G-CSF (Filgrastim, Millipore Sigma, 121181-53-1) (Stem Cell Technologies, Vancouver, BC, Canada).
• Structural surfaceomics reveals an AML-specific conformation of Integrin-β2 as a CAR-T therapy target

  Kamal Mandal, et al., bioRxiv - Cancer Biology 2022

  Quote: ... all the unwanted cells were labelled with magnet conjugated antibody cocktail which is separated using their EasySep magnetic stand leaving CD4 or CD8 cell in suspension using the vendor supplied EasySep Human CD4/CD8 T Cell Iso Kit (Stem Cell Technologies, 17952 for CD4 and 17953 for CD8). This negative selection approach results in isolation of untouched CD8 or CD4 T cells and stored frozen with 10% DMSO (MP Biomedicals ...